查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413853

製藥業人工智慧市場：按產品、技術、應用和最終用戶分類 - 2024-2030 年全球預測

Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

人工智慧在製藥領域的市場規模預計2023年為162.1億美元，2024年達到207.6億美元，預計2030年將達到973.5億美元，複合年成長率為29.18%。

人工智慧在製藥領域的全球市場

主要市場統計
基準年[2023] 162.1億美元
預測年份 [2024] 207.6億美元
預測年份 [2030] 973.5億美元
複合年成長率（%） 29.18%
人工智慧在醫藥市場-IMG1

製藥市場中的人工智慧（AI）是指將先進的機器學習演算法、自然語言處理和資料分析技術整合到全球製藥業的藥物研發、開發和製造流程中。為了改善治療效果而對個人化醫療的需求不斷成長，以及基因組學和高通量技術的進步產生了大量複雜的資料，需要先進的分析技術。然而，用於訓練機器學習模型的精選資料集的可得性有限，阻礙了人工智慧在醫學中的採用。然而，將巨量資料分析與人工智慧結合還可以提高我們對各種疾病分子機制的理解，並識別可能成為未來藥物標靶的新型生物標記。

區域洞察

在美國，由於先進技術的早期採用和政府的支援政策，醫藥人工智慧市場的環境正在改善。美國擁有多家領先的人工智慧新興企業，它們利用人工智慧進行藥物研發、分子建模、臨床試驗最佳化和個人化醫療。在美國，大型製藥企業正在與人工智慧主導的新興企業合作，並大力投資研究，以加速藥物研發發現和開發。在歐洲地區，法國、德國、英國等國紛紛推出國家戰略，推動人工智慧在醫藥等各產業的應用。儘管與其他地區相比進展緩慢，但中東國家正在透過人工智慧投資取得進展。非洲的潛力在於透過其不斷發展的製藥生態系統來應對其獨特的醫療保健挑戰。在亞太地區，以中國、日本和印度為首的人工智慧藥物領域正在取得顯著進展。此外，公共和私人對製藥基礎設施的投資不斷增加，為引入人工智慧創造了積極的環境。

FPNV定位矩陣

FPNV 定位矩陣對於評估製藥市場中的人工智慧至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對製藥市場人工智慧供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-人工智慧在醫藥領域的市場規模與預測是多少？

2-在人工智慧製藥市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-人工智慧在製藥市場的技術趨勢和法律規範是什麼？

4-製藥市場人工智慧主要供應商的市場佔有率是多少？

5-進入醫藥人工智慧市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對個人化醫療以改善治療結果的需求不斷成長
      • 利用人工智慧主導的方法來增強現有的藥物再利用策略
      • 生物醫學和臨床資料處理有待加強
    • 抑制因素
      • 開發和實施人工智慧解決方案的初始投資較高
    • 機會
      • 介紹針對製藥業的人工智慧為基礎的創新解決方案
      • 大量投資人工智慧藥物研發發現研究
    • 任務
      • 資料隱私和安全問題
  • 市場區隔分析
    • 它提供什麼：由於功能的改進，基於人工智慧的軟體的採用率有所提高
    • 科技：機器學習技術在製藥領域的使用越來越多
    • 應用：利用人工智慧解決方案簡化臨床試驗流程
    • 最終用戶：製藥和生物技術公司大規模採用人工智慧技術進行藥物研發和開發
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 製藥領域的人工智慧市場：透過提供

  • 硬體
    • 記憶
    • 通訊網路
    • 處理器
  • 服務
    • 部署與整合
    • 支援與維護
  • 軟體

第7章 製藥領域的人工智慧市場：依技術分類

  • 電腦視覺
  • 情境感知計算
  • 機器學習
  • 自然語言處理
  • 如何聯絡我們

第8章 製藥領域的人工智慧市場：依應用分類

  • 臨床試驗
  • 診斷支持與個人化治療
  • 藥物研發發現和發現
  • 製造業
  • 行銷

第9章 製藥業的人工智慧市場：依最終用戶分類

  • 製藥和生物技術公司
  • 調查機構

第10章 美洲製藥領域的人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區醫藥人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲製藥業的人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強

第14章競爭產品組合

  • 主要公司簡介
    • AiCure, LLC
    • Aspen Technology Inc
    • Atomwise Inc
    • BenevolentAI SA
    • BioSymetrics Inc.
    • BPGbio Inc.
    • Butterfly Network, Inc.
    • Cloud Pharmaceuticals, Inc.
    • CloudMedX Inc.
    • Cyclica Inc
    • Deargen Inc
    • Deep Genomics Incorporated
    • Euretos Services BV
    • Exscientia plc
    • Google LLC
    • Insilico Medicine
    • Intel Corporation
    • International Business Machines Corporation
    • InveniAI LLC
    • Isomorphic Labs
    • Microsoft Corporation
    • Novo Nordisk A/S
    • Oracle Corporation
    • Sanofi SA
    • Turbine Ltd.
    • Viseven Europe OU
    • XtalPi Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-A6768A62EE03

[199 Pages Report] The Artificial Intelligence in Pharmaceutical Market size was estimated at USD 16.21 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 29.18% to reach USD 97.35 billion by 2030.

Global Artificial Intelligence in Pharmaceutical Market

KEY MARKET STATISTICS
Base Year [2023] USD 16.21 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 97.35 billion
CAGR (%) 29.18%
Artificial Intelligence in Pharmaceutical Market - IMG1

Artificial intelligence (AI) in the pharmaceutical market refers to integrating advanced machine learning algorithms, natural language processing, and data analytics technologies into the drug discovery, development, and manufacturing processes of the global pharmaceutical industry. The growing demand for personalized medicine to improve treatment outcomes and advancements in genomics and high-throughput technologies generate large volumes of complex data requiring advanced analytical techniques. However, the limited availability of curated datasets for training machine learning models hinders the adoption of AI in pharmaceuticals. Nevertheless, integrating big data analytics with AI may also facilitate a better understanding of molecular mechanisms underlying various diseases or identify novel biomarkers that could be targets of future drugs; this further creates lucrative opportunities for the market.

Regional Insights

America provides an improved landscape for the AI in pharmaceutical market with an early adoption of advanced technologies and supportive government policies. The United States is home to several leading AI startups leveraging AI for drug discovery, molecular modeling, clinical trials optimization, and personalized medicine. In the U.S., major pharmaceutical firms are partnering with AI-driven startups and investing heavily in research to expedite drug discovery and development. In the European region, countries such as France, Germany, and the United Kingdom have introduced national strategies propelling AI applications across industries, including pharmaceuticals. Although slower in comparison to other regions, Middle Eastern countries are advancing through investment in AI. Africa's potential lies in addressing unique healthcare challenges through its developing pharma ecosystem. The Asia Pacific region showcases significant growth in AI-driven pharmaceutical advancements with China, Japan, and India at the forefront. In addition, increasing public-private investments in pharmaceutical manufacturing infrastructure provides a positive landscape for AI deployments.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Artificial Intelligence in Pharmaceutical Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Intelligence in Pharmaceutical Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aspen Technology Inc, Atomwise Inc, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Cloud Pharmaceuticals, Inc., CloudMedX Inc., Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google LLC, Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Microsoft Corporation, Novo Nordisk A/S, Oracle Corporation, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Hardware
      • Memory
      • Network
      • Processor
    • Services
      • Deployment & Integration
      • Support & Maintenance
    • Software
  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
    • Querying Method
  • Applications
    • Clinical Trials
    • Diagnostic Assistance & Personalized Treatment
    • Drug Development & Discovery
    • Manufacturing
    • Marketing
  • End-users
    • Pharma & Biotech Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Artificial Intelligence in Pharmaceutical Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Intelligence in Pharmaceutical Market?

3. What are the technology trends and regulatory frameworks in the Artificial Intelligence in Pharmaceutical Market?

4. What is the market share of the leading vendors in the Artificial Intelligence in Pharmaceutical Market?

5. Which modes and strategic moves are suitable for entering the Artificial Intelligence in Pharmaceutical Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Artificial Intelligence in Pharmaceutical Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicine to improve treatment outcomes
      • 5.1.1.2. Utilization of AI-driven approaches to enhance existing drug repurposing strategies
      • 5.1.1.3. Need to enhance processing of biomedical and clinical data
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment for developing and implementing AI solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative AI-based solutions for pharmaceutical industry
      • 5.1.3.2. Significant investments for AI drug discovery research
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offerings: Growing AI-based software adoption owing to its improved functionality & features
    • 5.2.2. Technology: Increasing utilization of machine learning technology in the pharmaceutical sector
    • 5.2.3. Applications: Improving the efficiency of clinical trial process through AI solutions
    • 5.2.4. End-users: Significant implementation of AI technologies by pharma & biotech companies for drug discovery & development
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Artificial Intelligence in Pharmaceutical Market, by Offering

  • 6.1. Introduction
  • 6.2. Hardware
    • 6.3.1. Memory
    • 6.3.2. Network
    • 6.3.3. Processor
  • 6.3. Services
    • 6.4.1. Deployment & Integration
    • 6.4.2. Support & Maintenance
  • 6.4. Software

7. Artificial Intelligence in Pharmaceutical Market, by Technology

  • 7.1. Introduction
  • 7.2. Computer Vision
  • 7.3. Context-Aware Computing
  • 7.4. Machine Learning
  • 7.5. Natural Language Processing
  • 7.6. Querying Method

8. Artificial Intelligence in Pharmaceutical Market, by Applications

  • 8.1. Introduction
  • 8.2. Clinical Trials
  • 8.3. Diagnostic Assistance & Personalized Treatment
  • 8.4. Drug Development & Discovery
  • 8.5. Manufacturing
  • 8.6. Marketing

9. Artificial Intelligence in Pharmaceutical Market, by End-users

  • 9.1. Introduction
  • 9.2. Pharma & Biotech Companies
  • 9.3. Research Institutes

10. Americas Artificial Intelligence in Pharmaceutical Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Pharmaceutical Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Pharmaceutical Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Launch of Insilico's Phase II Program Highlights Generative AI Momentum
      • 13.3.2.2. Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AiCure, LLC
    • 14.1.2. Aspen Technology Inc
    • 14.1.3. Atomwise Inc
    • 14.1.4. BenevolentAI SA
    • 14.1.5. BioSymetrics Inc.
    • 14.1.6. BPGbio Inc.
    • 14.1.7. Butterfly Network, Inc.
    • 14.1.8. Cloud Pharmaceuticals, Inc.
    • 14.1.9. CloudMedX Inc.
    • 14.1.10. Cyclica Inc
    • 14.1.11. Deargen Inc
    • 14.1.12. Deep Genomics Incorporated
    • 14.1.13. Euretos Services BV
    • 14.1.14. Exscientia plc
    • 14.1.15. Google LLC
    • 14.1.16. Insilico Medicine
    • 14.1.17. Intel Corporation
    • 14.1.18. International Business Machines Corporation
    • 14.1.19. InveniAI LLC
    • 14.1.20. Isomorphic Labs
    • 14.1.21. Microsoft Corporation
    • 14.1.22. Novo Nordisk A/S
    • 14.1.23. Oracle Corporation
    • 14.1.24. Sanofi SA
    • 14.1.25. Turbine Ltd.
    • 14.1.26. Viseven Europe OU
    • 14.1.27. XtalPi Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET DYNAMICS
  • FIGURE 7. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 12. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 8. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEMORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NETWORK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT & INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPORT & MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC ASSISTANCE & PERSONALIZED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MARKETING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 281. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 282. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET LICENSE & PRICING